These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17230508)

  • 1. Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells.
    Flaig TW; Su LJ; Harrison G; Agarwal R; Glodé LM
    Int J Cancer; 2007 May; 120(9):2028-33. PubMed ID: 17230508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
    Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
    Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
    Tyagi A; Bhatia N; Condon MS; Bosland MC; Agarwal C; Agarwal R
    Prostate; 2002 Nov; 53(3):211-7. PubMed ID: 12386921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.
    Vue B; Zhang S; Zhang X; Parisis K; Zhang Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2016 Feb; 109():36-46. PubMed ID: 26748997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death.
    Dhanalakshmi S; Agarwal P; Glode LM; Agarwal R
    Int J Cancer; 2003 Sep; 106(5):699-705. PubMed ID: 12866029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels.
    Singh RP; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R
    Cancer Res; 2002 Jun; 62(11):3063-9. PubMed ID: 12036915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells.
    Zhang S; Vue B; Huang M; Zhang X; Lee T; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3226-3231. PubMed ID: 27261177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice.
    Singh RP; Raina K; Sharma G; Agarwal R
    Clin Cancer Res; 2008 Dec; 14(23):7773-80. PubMed ID: 19047104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models.
    Xie X; Eberding A; Madera C; Fazli L; Jia W; Goldenberg L; Gleave M; Guns ES
    J Urol; 2006 May; 175(5):1926-31. PubMed ID: 16600800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer.
    Flaig TW; Glodé M; Gustafson D; van Bokhoven A; Tao Y; Wilson S; Su LJ; Li Y; Harrison G; Agarwal R; Crawford ED; Lucia MS; Pollak M
    Prostate; 2010 Jun; 70(8):848-55. PubMed ID: 20127732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
    Singh RP; Sharma G; Dhanalakshmi S; Agarwal C; Agarwal R
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy inhibition enhances silibinin-induced apoptosis by regulating reactive oxygen species production in human prostate cancer PC-3 cells.
    Kim SH; Kim KY; Yu SN; Park SK; Choi HD; Ji JH; Ahn SC
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):151-6. PubMed ID: 26522224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
    Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
    Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Tyagi AK; Agarwal C; Chan DC; Agarwal R
    Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin combination with arsenic strongly inhibits survival and invasiveness of human prostate carcinoma cells.
    Prajapati V; Kale RK; Singh RP
    Nutr Cancer; 2015; 67(4):647-58. PubMed ID: 25868784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of anticancer activity by silibinin and paclitaxel combination on the ovarian cancer.
    Pashaei-Asl F; Pashaei-Asl R; Khodadadi K; Akbarzadeh A; Ebrahimie E; Pashaiasl M
    Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1483-1487. PubMed ID: 28884602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silibinin induces apoptosis and inhibits proliferation of estrogen receptor (ER)-negative breast carcinoma cells through suppression of nuclear factor kappa B activation.
    Yousefi M; Ghaffari SH; Zekri A; Hassani S; Alimoghaddam K; Ghavamzadeh A
    Arch Iran Med; 2014 May; 17(5):366-71. PubMed ID: 24784867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of cytotoxic effects induced by mitoxantrone on hormone-refractory metastatic prostate cancer cells by co-targeting epidermal growth factor receptor and hedgehog signaling cascades.
    Mimeault M; Mehta PP; Hauke R; Henichart JP; Depreux P; Lin MF; Batra SK
    Growth Factors; 2007 Dec; 25(6):400-16. PubMed ID: 18365871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas-mediated killing of primary prostate cancer cells is increased by mitoxantrone and docetaxel.
    Symes JC; Kurin M; Fleshner NE; Medin JA
    Mol Cancer Ther; 2008 Sep; 7(9):3018-28. PubMed ID: 18790782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo.
    Miyake H; Chi KN; Gleave ME
    Clin Cancer Res; 2000 May; 6(5):1655-63. PubMed ID: 10815883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.